Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Objective To investigate whether funding of drug studies by the pharmaceutical industry is
associated with outcomes that are favourable to the funder and whether the methods of trials …
associated with outcomes that are favourable to the funder and whether the methods of trials …
What is the price of life and why doesn't it increase at the rate of inflation?
AN ARTICLE in the February 2000 is-sue of JAMA concluded that annual retinal screening
for many individuals with type 2 diabetes mellitus may not be warranted on grounds of cost …
for many individuals with type 2 diabetes mellitus may not be warranted on grounds of cost …
Health care economic analyses and value-based medicine
MM Brown, GC Brown, S Sharma, J Landy - Survey of ophthalmology, 2003 - Elsevier
Health care economic analyses are becoming increasingly important in the evaluation of
health care interventions, including many within ophthalmology. Encompassed with the …
health care interventions, including many within ophthalmology. Encompassed with the …
Quantitative analysis of sponsorship bias in economic studies of antidepressants
CB Baker, MT Johnsrud, ML Crismon… - The British Journal of …, 2003 - cambridge.org
BackgroundConcern is widespread about potential sponsorship influence on research,
especially in pharmacoeconomic studies. Quantitative analysis of possible bias in such …
especially in pharmacoeconomic studies. Quantitative analysis of possible bias in such …
[图书][B] What's Your Life Worth?: Health Care Rationing--who Lives? who Dies? who Decides?
D Dranove - 2003 - books.google.com
Examines the issue of rationing including its concept, examples of rationing around the
world and in the US, cost-effectiveness and cost-benefit research, quality and value of life …
world and in the US, cost-effectiveness and cost-benefit research, quality and value of life …
The influence of cost-effectiveness information on physicians' cancer screening recommendations
Physicians are increasingly faced with choices in which one screening strategy is both more
effective and more expensive than another. One way to make such choices is to examine the …
effective and more expensive than another. One way to make such choices is to examine the …
Setting prices for new vaccines (in advance)
TG McGuire - International Journal of Health Care Finance and …, 2003 - Springer
New vaccines have high social value, but the incentives to firms to develop new vaccines
appear to be weak. This paper recommends setting a procurement price for a new vaccine …
appear to be weak. This paper recommends setting a procurement price for a new vaccine …
[PDF][PDF] La productividad de las innovaciones médicas y farmacéuticas
J Puig-Junoy - Humanitas, 2003 - jaumepuigjunoy.cat
El cambio tecnológico en los servicios de salud se ha identificado en numerosas ocasiones
como el factor que más ha influido en el crecimiento del gasto sanitario. Resulta, pues …
como el factor que más ha influido en el crecimiento del gasto sanitario. Resulta, pues …
Three criteria of acceptable risk
NC Lind - Structural Concrete, 2003 - icevirtuallibrary.com
Structural safety is a part of general safety in a society. Safety factors should conform to a
general rationale for all life safety. Two rationales are presented here, using a principle of …
general rationale for all life safety. Two rationales are presented here, using a principle of …
[图书][B] The effect of direct-to-consumer advertising on prescription drug use among the insured
RA Hansen - 2003 - search.proquest.com
Since August of 1997, when the Food and Drug Administration issued a draft guidance for
direct-to-consumer advertising of prescription drugs, consumer directed advertising has …
direct-to-consumer advertising of prescription drugs, consumer directed advertising has …